Latest filing published 17 Aug 2022 for Xtant Medical Holdings, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Matthew Rizzo: trading record in brief
This profile gathers the share dealings of Matthew Rizzo in Xtant Medical Holdings, Inc., where the filings describe the role as board member. Over a trading history stretching from 14 February 2018 to 15 August 2022, the count stands at 16 filings.
Purchases make up the whole of the open-market record (2 purchases, €5.5M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 14 share grants.
The record was last updated on 17 August 2022 with a share grant in Xtant Medical Holdings, Inc. The latest purchase dates back some time: it was published 3,178 days ago, on 26 February 2018. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Matthew Rizzo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 215,415 shares0Common Stock, $0.000001 par valueSEC:0001235802-22-000094:0
- 85,337 shares0Common StockSEC:0001235802-21-000103:0
2 of 2 declarations